Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid Arthritis

NCT00420927 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1032

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

BIOLOGICAL: adalimumab
DRUG: methotrexate
BIOLOGICAL: placebo

Sponsor

Abbott